Ablynx’s Nanobodies® Take in Another Big Pharma
By Sally Mardikian PhD
Pharma Deals Review: Vol 2008 Issue 100 (Table of Contents)
Published: 4 Sep-2008
DOI: 10.3833/pdr.v2008.i100.131 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Ablynx continues to rack up the deals for its potentially lucrative Nanobodies® and Merck Serono is the latest to enter into an agreement with the company...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS